SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-322819
Filing Date
2013-08-07
Accepted
2013-08-07 06:15:59
Documents
4
Period of Report
2013-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d581259d8k.htm 8-K 16381
2 EX-99.1 d581259dex991.htm EX-99.1 498236
3 GRAPHIC g581259ex99_1.jpg GRAPHIC 12079
4 GRAPHIC g581259logo.jpg GRAPHIC 6043
  Complete submission text file 0001193125-13-322819.txt   541236
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 131015702
SIC: 2834 Pharmaceutical Preparations